US equities
|
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
NVDA
$204.64
▼-4.22%
INTC
$65.76
▼-28.58%
MU
$884.74
▼-5.30%
AMZN
$240.35
▼-1.41%
AAPL
$344.63
▼-1.23%
SNDK
$1,150.89
▼-13.47%
AMD
$504.80
▼-10.88%
MSFT
$521.91
▼-1.55%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Toronto Institute of Pharmaceutical Technology
Recent news which mentions Toronto Institute of Pharmaceutical Technology
New Batch Of Psilocybin Microdose Capsules Is Ready, Learn All The Details
September 17, 2022
Tickers
NMLSF
Tags
Health Canada Approval
News
Autism Spectrum Disorde
From
Benzinga
Nova Mentis NM-1001 Psilocybin Compound Gets DEA Approval For Export, Here's What Happened
June 07, 2022
Tickers
NMLSF
Tags
Penny Stocks
Cannabis
Biotech
From
Benzinga
Nova Mentis Is Looking To Treat Autism With Psilocybin
April 07, 2022
Tickers
NMLSF
Tags
Market News
Nova Mentis Life Science Corp/
Toronto Institute of Pharmaceutical Technology
From
Benzinga